FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Barry Coller

Research Profile

Anatomy

Chemicals & Drugs

Physiology

Disorders

Living Beings

Mouse

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Teresa Brophy; Barry S Coller; Jasimuddin Ahamed
Identification of the Thiol Isomerase-binding Peptide, Mastoparan, as a Novel Inhibitor of Shear-induced Transforming Growth Factor β1 (TGF-β1) Activation.
Valentin Fuster; Dominick J Angiolillo; Eric R Bates; Deepak L Bhatt; Robert M Califf; David J Cohen; Barry S Coller; Bruce Furie; W Keith Hoots; Jean-Sebastien Hulot; Kenneth G Mann; Jessica L Mega; Alan D Michelson; Kiran Musunuru; Christopher J O'Donnell; Matthew J Price; Yves D Rosenberg; Marc S Sabatine; David J Schneider; Daniel I Simon; Jeffrey I Weitz; Marlene S Williams; Ahmed A K Hasan
Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group.
Ana Negri; Barry S Coller; Jihong Li; Sarasija Naini; Marta Filizola
Structure-based virtual screening of small-molecule antagonists of platelet integrin αIIbβ3 that do not prime the receptor to bind ligand.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Barry Coller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Teresa Brophy; Barry S Coller; Jasimuddin Ahamed
Identification of the Thiol Isomerase-binding Peptide, Mastoparan, as a Novel Inhibitor of Shear-induced Transforming Growth Factor β1 (TGF-β1) Activation.
The Journal of biological chemistry 2013;288(15):10628-39.
2012: Valentin Fuster; Dominick J Angiolillo; Eric R Bates; Deepak L Bhatt; Robert M Califf; David J Cohen; Barry S Coller; Bruce Furie; W Keith Hoots; Jean-Sebastien Hulot; Kenneth G Mann; Jessica L Mega; Alan D Michelson; Kiran Musunuru; Christopher J O'Donnell; Matthew J Price; Yves D Rosenberg; Marc S Sabatine; David J Schneider; Daniel I Simon; Jeffrey I Weitz; Marlene S Williams; Ahmed A K Hasan
Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group.
Circulation 2012;126(13):1645-62.
2012: Ana Negri; Barry S Coller; Jihong Li; Sarasija Naini; Marta Filizola
Structure-based virtual screening of small-molecule antagonists of platelet integrin αIIbβ3 that do not prime the receptor to bind ligand.
Journal of computer-aided molecular design 2012;26(9):1005-15.
2012: Paula James; Barry S Coller
Phenotyping bleeding.
Current opinion in hematology 2012;19(5):406-12.
2012: Jieqing Zhu; Jianghai Zhu; Richard Aster; Daniel Bougie; Won-Seok Choi; Marta Filizola; Wenwei Huang; Jihong Li; Joshua G McCoy; Sarasija Naini; Ana Negri; Mark Rasmussen; Min Shen; Timothy A Springer; Craig J Thomas; Barry S Coller
Structure-guided design of a high-affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg²⁺ binding to the MIDAS.
Science translational medicine 2012;4(125):125ra32.
2012: Alexander Meyer; Jiaxiang Qu; Wei Wang; Barry S Coller; Lori Croft; Jay L Degen; Jasimuddin Ahamed
Platelet TGF-β1 contributions to plasma TGF-β1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload.
Blood 2012;119(4):1064-74.
2011: Rhonda G Kost; Laura M Lee; Jennifer Yessis; Barry S Coller; David K Henderson
Assessing research participants' perceptions of their clinical research experiences.
Clinical and translational science 2011;4(6):403-13.
2011: Barry S Coller
Realigning incentives to achieve health care reform.
JAMA : the journal of the American Medical Association 2011;306(2):204-5.
2011: A C Mauer; N A Khazanov; Natasha Levenkova; S Tian; E M Barbour; C Khalida; J N Tobin; Barry S Coller
Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults.
Journal of thrombosis and haemostasis : JTH 2011;9(1):100-8.
2010: Jieqing Zhu; Jianghai Zhu; Ana Negri; Davide Provasi; Marta Filizola; Barry S Coller; Timothy A Springer
Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening.
Blood 2010;116(23):5050-9.
2010: Robert Blue; Jihong Li; Jonathan Steinberger; Marta Murcia; Marta Filizola; Barry S Coller
Effects of limiting extension at the alphaIIb genu on ligand binding to integrin alphaIIbbeta3.
The Journal of biological chemistry 2010;285(23):17604-13.
2009: Barry S Coller; Robert M Califf
Traversing the valley of death: a guide to assessing prospects for translational success.
Science translational medicine 2009;1(10):10cm9.
2009: Davide Provasi; Marta Murcia; Barry S Coller; Marta Filizola
Targeted molecular dynamics reveals overall common conformational changes upon hybrid domain swing-out in beta3 integrins.
Proteins 2009;77(2):477-89.
2009: Andreas C Mauer; Edward M Barbour; Nickolay A Khazanov; Natasha Levenkova; Shamim A Mollah; Barry S Coller
Creating an ontology-based human phenotyping system: The Rockefeller University bleeding history experience.
Clinical and translational science 2009;2(5):382-5.
2009: Robert Blue; M Anna Kowalska; Jessica Hirsch; Marta Murcia; Christin A Janczak; Amanda Harrington; M Jirouskova; Jihong Li; Rudy Fuentes; Michael A Thornton; Marta Filizola; Mortimer Poncz; Barry S Coller
Structural and therapeutic insights from the species specificity and in vivo antithrombotic activity of a novel alphaIIb-specific alphaIIbbeta3 antagonist.
Blood 2009;114(1):195-201.
2009: Jasimuddin Ahamed; Christin A Janczak; Knut M Wittkowski; Barry S Coller
In vitro and in vivo evidence that thrombospondin-1 (TSP-1) contributes to stirring- and shear-dependent activation of platelet-derived TGF-beta1.
PloS one 2009;4(8):e6608.
2008: Barry S Coller
Thinking globally, acting locally: Rockefeller University's enterprising CTSA work.
Clinical and translational science 2008;1(3):190-1.
2008: Jasimuddin Ahamed; Nathalie Burg; Keiji Yoshinaga; Christin A Janczak; Daniel B Rifkin; Barry S Coller
In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1.
Blood 2008;112(9):3650-60.
2008: Barry S Coller; Sanford J Shattil
The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.
Blood 2008;112(8):3011-25.
2008: Barry S Coller
Translational research: forging a new cultural identity.
The Mount Sinai journal of medicine, New York 2008;75(5):478-87.
2008: Arun S Shet; Thomas J Hoffmann; M Jirouskova; Christin A Janczak; Jacqueline R M Stevens; Adewole Adamson; Narla Mohandas; Elizabeth A Manci; Therese Cynober; Barry S Coller
Morphological and functional platelet abnormalities in Berkeley sickle cell mice.
Blood cells, molecules & diseases 2008;41(1):109-18.
2008: Marta Murcia; M Jirouskova; Jihong Li; Barry S Coller; Marta Filizola
Functional and computational studies of the ligand-associated metal binding site of beta3 integrins.
Proteins 2008;71(4):1779-91.
2008: Robert Blue; Marta Murcia; Charles Karan; Markéta Jirousková; Barry S Coller
Application of high-throughput screening to identify a novel alphaIIb-specific small- molecule inhibitor of alphaIIbbeta3-mediated platelet interaction with fibrinogen.
Blood 2008;111(3):1248-56.
2007: Ronit Mor-Cohen; Nurit Rosenberg; Hava Peretz; meytal landau; Barry S Coller; Abdalla Awidi; Uri Seligsohn
Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3.
Thrombosis and haemostasis 2007;98(6):1257-65.
2007: Markéta Jirousková; Jyoti K Jaiswal; Barry S Coller
Ligand density dramatically affects integrin alpha IIb beta 3-mediated platelet signaling and spreading.
Blood 2007;109(12):5260-9.
2007: W Beau Mitchell; Jihong Li; Marta Murcia; Nathalie Valentin; Peter J Newman; Barry S Coller
Mapping early conformational changes in alphaIIb and beta3 during biogenesis reveals a potential mechanism for alphaIIbbeta3 adopting its bent conformation.
Blood 2007;109(9):3725-32.
2006: Barry S Coller
The physician-scientist, the state, and the oath: thoughts for our times.
The Journal of clinical investigation 2006;116(10):2567-70.
2006: Everette J R Nelson; Sukesh C Nair; Hava Peretz; Barry S Coller; Uri Seligsohn; Mammen Chandy; Alok Srivastava
Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients.
Journal of thrombosis and haemostasis : JTH 2006;4(8):1730-7.
2006: Hava Peretz; Nurit Rosenberg; meytal landau; Saly Usher; Everette J R Nelson; Ronit Mor-Cohen; Deborah L French; Beau W Mitchell; Sukesh C Nair; Mammen Chandy; Barry S Coller; Alok Srivastava; Uri Seligsohn
Molecular diversity of Glanzmann thrombasthenia in southern India: new insights into mRNA splicing and structure-function correlations of alphaIIbbeta3 integrin (ITGA2B, ITGB3).
Human mutation 2006;27(4):359-69.
2006: W Beau Mitchell; JiHong Li; Deborah L French; Barry S Coller
alphaIIbbeta3 biogenesis is controlled by engagement of alphaIIb in the calnexin cycle via the N15-linked glycan.
Blood 2006;107(7):2713-9.
2006: Elizabeth A Manci; Cheryl A Hillery; Carol A Bodian; Zheng Gang Zhang; Gerard A Lutty; Barry S Coller
Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease.
Blood 2006;107(4):1651-8.
2005: Everette J R Nelson; Jihong Li; W Beau Mitchell; Mammen Chandy; Alok Srivastava; Barry S Coller
Three novel beta-propeller mutations causing Glanzmann thrombasthenia result in production of normally stable pro-alphaIIb, but variably impaired progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
Journal of thrombosis and haemostasis : JTH 2005;3(12):2773-83.
2005: Nurit Rosenberg; H Hauschner; Hava Peretz; Ronit Mor-Cohen; meytal landau; Boris Shenkman; Gili Kenet; Barry S Coller; abdalla awidi; Uri Seligsohn
A 13-bp deletion in alpha(IIb) gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombasthenia.
Journal of thrombosis and haemostasis : JTH 2005;3(12):2764-72.
2005: Jaehyung Cho; Jay L Degen; Barry S Coller; Deane F Mosher
Fibrin but not adsorbed fibrinogen supports fibronectin assembly by spread platelets. Effects of the interaction of alphaIIb beta3 with the C terminus of the fibrinogen gamma-chain.
The Journal of biological chemistry 2005;280(42):35490-8.
2005: Barry S Coller
Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?
Arteriosclerosis, thrombosis, and vascular biology 2005;25(4):658-70.
2004: Tsan Xiao; Junichi Takagi; Barry S Coller; Jia-huai Wang; Timothy A Springer
Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics.
Nature 2004;432(7013):59-67.
2004: Tullio Palmerini; Barry S Coller; Vittorio Cervi; Luciana Tomasi; Antonio Marzocchi; Cinzia Marrozzini; Ornella Leone; Milena Piccioli; Angelo Branzi
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system.
Journal of the American College of Cardiology 2004;44(8):1570-7.
2004: Andrea Artoni; JiHong Li; Beau Mitchell; Jian Ruan; Junichi Takagi; Timothy A Springer; Deborah L French; Barry S Coller
Integrin beta3 regions controlling binding of murine mAb 7E3: implications for the mechanism of integrin alphaIIbbeta3 activation.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(36):13114-20.
2004: Carlo Patrono; Barry S Coller; garret fitzgerald; Jack Hirsh; Gerald J Roth
Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest 2004;126(3 Suppl):234S-264S.
2004: Deborah L French; Steven Fruchtman; W Beau Mitchell; Barry S Coller; Hava Peretz
Evidence for megakaryocyte engraftment following reduced-intensity conditioning.
Experimental hematology 2004;32(9):877-80.
2004: Marta Filizola; Sergio A Hassan; Andrea Artoni; Barry S Coller; HAREL WEINSTEIN
Mechanistic insights from a refined three-dimensional model of integrin alphaIIbbeta3.
The Journal of biological chemistry 2004;279(23):24624-30.
2004: Markéta Jirousková; Igor Chereshnev; Heikki Väänänen; Jay L Degen; Barry S Coller
Antibody blockade or mutation of the fibrinogen gamma-chain C-terminus is more effective in inhibiting murine arterial thrombus formation than complete absence of fibrinogen.
Blood 2004;103(6):1995-2002.
2004: Aslihan Turhan; Pegah Jenab; Pierre Bruhns; Jeffrey V Ravetch; Barry S Coller; Paul S. Frenette
Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes.
Blood 2004;103(6):2397-400.
2004: Barry S Coller
Reflections on being a Chair of Medicine, 1993 to 2001 - Part 2.
The American journal of medicine 2004;116(2):141-4.
2004: Barry S Coller
Reflections on being a chair of medicine, 1993 to 2001--part 1.
The American journal of medicine 2004;116(1):68-72.
2003: Tomas Scheiner; Markéta Jirousková; Chandrasekaran Nagaswami; Barry S Coller; John W Weisel
A monoclonal antibody to the fibrinogen gamma-chain alters fibrin clot structure and its properties by producing short, thin fibers arranged in bundles.
Journal of thrombosis and haemostasis : JTH 2003;1(12):2594-602.
2003: Li Zhang; Zheng Gang Zhang; Rui Lan Zhang; Daniel Morris; Mei Lu; Barry S Coller; Michael Chopp
Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
Circulation 2003;107(22):2837-43.
2003: Virgilio Evangelista; Stefano Manarini; Barry S Coller; Susan Smyth
Role of P-selectin, beta2-integrins, and Src tyrosine kinases in mouse neutrophil-platelet adhesion.
Journal of thrombosis and haemostasis : JTH 2003;1(5):1048-54.
2003: Michael A Matthay; Guy A Zimmerman; Charles Esmon; Jahar Bhattacharya; Barry S Coller; Claire Doerschuk; Joanna Floros; Michael A Gimbrone; Eric Hoffman; Rolf D Hubmayr; Mark Leppert; Sadis Matalon; Robert Munford; Polly Parsons; Arthur Slutsky; Kevin Tracey; Peter Ward; Dorothy B Gail; Andrea L Harabin
Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group.
American journal of respiratory and critical care medicine 2003;167(7):1027-35.
2003: W Beau Mitchell; Ji Hong Li; Fiza Singh; Alan D Michelson; James Bussel; Barry S Coller; Deborah L French
Two novel mutations in the alpha IIb calcium-binding domains identify hydrophobic regions essential for alpha IIbbeta 3 biogenesis.
Blood 2003;101(6):2268-76.
2003: Raymonda Rastegar; David J Harnick; Peter Weidemann; Valentin Fuster; Barry S Coller; Juan J Badimon; James H Chesebro; Martin E Goldman
Spontaneous echo contrast videodensity is flow-related and is dependent on the relative concentrations of fibrinogen and red blood cells.
Journal of the American College of Cardiology 2003;41(4):603-10.
2003: Dipti Patel; Heikki Väänänen; Markéta Jirousková; Thomas Hoffmann; Carol Bodian; Barry S Coller
Dynamics of GPIIb/IIIa-mediated platelet-platelet interactions in platelet adhesion/thrombus formation on collagen in vitro as revealed by videomicroscopy.
Blood 2003;101(3):929-36.
2002: Barry S Coller
Science and humanism: the twin pillars of medicine.
The Mount Sinai journal of medicine, New York 2002;69(5):277-9.
2002: Sona Nair; Jihong Li; W Beau Mitchell; Dipika Mohanty; Barry S Coller; Deborah L French
Two new beta3 integrin mutations in Indian patients with Glanzmann thrombasthenia: localization of mutations affecting cysteine residues in integrin beta3.
Thrombosis and haemostasis 2002;88(3):503-9.
2002: Tullio Palmerini; Mark A Nedelman; Lesley E Scudder; Marian T Nakada; Robert E Jordan; Susan Smyth; Ronald E Gordon; John T Fallon; Barry S Coller
Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates.
Journal of the American College of Cardiology 2002;40(2):360-6.
2002: Barry S Coller; Paul Klotman; Lawrence G Smith
Professing and living the oath: teaching medicine as a profession.
The American journal of medicine 2002;112(9):744-8.
2002: Aslihan Turhan; Linnea A Weiss; Narla Mohandas; Barry S Coller; Paul S. Frenette
Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(5):3047-51.
2002: O Shpilberg; I Rabi; K Schiller; R Walden; D Harats; K S Tyrrell; Barry S Coller; Uri Seligsohn
Patients with Glanzmann thrombasthenia lacking platelet glycoprotein alpha(IIb)beta(3) (GPIIb/IIIa) and alpha(v)beta(3) receptors are not protected from atherosclerosis.
Circulation 2002;105(9):1044-8.
2001: Markéta Jirousková; Susan Smyth; B Kudryk; Barry S Coller
A hamster antibody to the mouse fibrinogen gamma chain inhibits platelet-fibrinogen interactions and FXIIIa-mediated fibrin cross-linking, and facilitates thrombolysis.
Thrombosis and haemostasis 2001;86(4):1047-56.
2001: Zheng Gang Zhang; Li Zhang; Wayne Tsang; Anton Goussev; Cecylia Powers; Khang-Loon Ho; Daniel Morris; Susan Smyth; Barry S Coller; Michael Chopp
Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion.
Brain research 2001;912(2):181-94.
2001: Susan Smyth; Ernane D Reis; Heikki Väänänen; Wandi Zhang; Barry S Coller
Variable protection of beta 3-integrin--deficient mice from thrombosis initiated by different mechanisms.
Blood 2001;98(4):1055-62.
2001: Barry S Coller
Anti-GPIIb/IIIa drugs: current strategies and future directions.
Thrombosis and haemostasis 2001;86(1):427-43.
2001: Susan Smyth; Ernane D Reis; Wandi Zhang; John T Fallon; Ronald E Gordon; Barry S Coller
Beta(3)-integrin-deficient mice but not P-selectin-deficient mice develop intimal hyperplasia after vascular injury: correlation with leukocyte recruitment to adherent platelets 1 hour after injury.
Circulation 2001;103(20):2501-7.
2001: Andrew S Dunn; Clyde Schechter; A Gotlin; D Vomvolakis; E Jacobs; Henry S Sacks; Barry S Coller
Outpatient treatment of deep venous thrombosis in diverse inner-city patients.
The American journal of medicine 2001;110(6):458-62.
2001: Markéta Jirousková; Barry S Coller
Platelet adhesion to fibrinogen coated at various densities.
Annals of the New York Academy of Sciences 2001;936():464-5.
2001: C Patrono; Barry S Coller; J E Dalen; garret fitzgerald; V Fuster; M Gent; J Hirsh; Gerald J Roth
Platelet-active drugs : the relationships among dose, effectiveness, and side effects.
Chest 2001;119(1 Suppl):39S-63S.
2000: Susan Smyth; DA Tsakiris; Lesley E Scudder; Barry S Coller
Structure and function of murine alphaIIbbeta3 (GPIIb/IIIa): studies using monoclonal antibodies and beta3-null mice,.
Thrombosis and haemostasis 2000;84(6):1103-8.
2000: R Hayes; James H Chesebro; Valentin Fuster; G Dangas; John T Fallon; Samin K Sharma; Barry S Coller; L Badimon; Jonathan D Marmur; Juan J Badimon
Antithrombotic effects of abciximab.
The American journal of cardiology 2000;85(10):1167-72.
2000: D O Nutter; J S Bond; Barry S Coller; R M D'Alessandri; Bruce Gewertz; L M Nora; J P Perkins; T S Shomaker; R T Watson
Measuring faculty effort and contributions in medical education.
Academic medicine : journal of the Association of American Medical Colleges 2000;75(2):199-207.
2000: Dhananjay K Kaul; Han-Mou Tsai; Xiao-du Liu; Marian T Nakada; Ronald L Nagel; Barry S Coller
Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor.
Blood 2000;95(2):368-74.
2000: RB Basani; Deborah L French; Gaston Vilaire; D L Brown; F Chen; Barry S Coller; JM Derrick; T Kent Gartner; Joel S Bennett; Mortimer Poncz
A naturally occurring mutation near the amino terminus of alphaIIb defines a new region involved in ligand binding to alphaIIbbeta3.
Blood 2000;95(1):180-8.
1999: Steven R Steinhubl; K Kottke-Marchant; D J Moliterno; M L Rosenthal; N K Godfrey; Barry S Coller; Eric J Topol; AM Lincoff
Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention.
Circulation 1999;100(19):1977-82.
1999: S Lengweiler; Susan Smyth; M Jirouskova; Lesley E Scudder; H Park; T Moran; Barry S Coller
Preparation of monoclonal antibodies to murine platelet glycoprotein IIb/IIIa (alphaIIbbeta3) and other proteins from hamster-mouse interspecies hybridomas.
Biochemical and biophysical research communications 1999;262(1):167-73.
1999: Barry S Coller
Binding of abciximab to alpha V beta 3 and activated alpha M beta 2 receptors: with a review of platelet-leukocyte interactions.
Thrombosis and haemostasis 1999;82(2):326-36.
1999: Barry S Coller
Potential non-glycoprotein IIb/IIIa effects of abciximab.
American heart journal 1999;138(1 Pt 2):S1-5.
1999: Andrew S Dunn; Barry S Coller
Outpatient treatment of deep vein thrombosis: translating clinical trials into practice.
The American journal of medicine 1999;106(6):660-9.
1999: J W Smith; Steven R Steinhubl; A Michael Lincoff; J C Coleman; T T Lee; R S Hillman; Barry S Coller
Rapid platelet-function assay: an automated and quantitative cartridge-based method.
Circulation 1999;99(5):620-5.
1999: Barry S Coller
Monitoring platelet GPIIb/IIIa antagonist therapy.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1999;10 Suppl 1():S81-6.
1999: DA Tsakiris; Lesley E Scudder; Kairbaan M Hodivala-Dilke; Richard O Hynes; Barry S Coller
Hemostasis in the mouse (Mus musculus): a review.
Thrombosis and haemostasis 1999;81(2):177-88.
1999: Z T Shi; Veena Afzal; Barry S Coller; D Patel; Joel Anne Chasis; Marilyn Parra; Gloria Lee; C Paszty; M Stevens; Loren D Walensky; Luanne L Peters; Narla Mohandas; E Rubin; John G Conboy
Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities.
The Journal of clinical investigation 1999;103(3):331-40.
1999: Suzette Béguin; R Kumar; IM Keularts; U Seligsohn; Barry S Coller; Coenraad Hemker
Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor.
Blood 1999;93(2):564-70.
1999: J A Varner; Marian T Nakada; Robert E Jordan; Barry S Coller
Inhibition of angiogenesis and tumor growth by murine 7E3, the parent antibody of c7E3 Fab (abciximab; ReoPro).
Angiogenesis 1999;3(1):53-60.
1999: Kairbaan M Hodivala-Dilke; KP McHugh; DA Tsakiris; Helen Rayburn; Denise Crowley; MH Ullman-Culleré; F Patrick Ross; Barry S Coller; Steven L Teitelbaum; Richard O Hynes
Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.
The Journal of clinical investigation 1999;103(2):229-38.
1998: C Patrono; Barry S Coller; J E Dalen; V Fuster; M Gent; L A Harker; J Hirsh; Gerald J Roth
Platelet-active drugs: the relationships among dose, effectiveness, and side effects.
Chest 1998;114(5 Suppl):470S-488S.
1998: Marlene S Williams; Barry S Coller; H J Väänänen; Lesley E Scudder; Samin K Sharma; Jonathan D Marmur
Activation of platelets in platelet-rich plasma by rotablation is speed-dependent and can be inhibited by abciximab (c7E3 Fab; ReoPro).
Circulation 1998;98(8):742-8.
1998: G Dangas; Juan J Badimon; Barry S Coller; John T Fallon; Samin K Sharma; R M Hayes; Perwaiz Meraj; John A Ambrose; Jonathan D Marmur
Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(8):1342-9.
1998: Deborah L French; Barry S Coller; Saly Usher; R Berkowitz; C Eng; Uri Seligsohn; Hava Peretz
Prenatal diagnosis of Glanzmann thrombasthenia using the polymorphic markers BRCA1 and THRA1 on chromosome 17.
British journal of haematology 1998;102(2):582-7.
1998: K A Moskowitz; B Kudryk; Barry S Coller
Fibrinogen coating density affects the conformation of immobilized fibrinogen: implications for platelet adhesion and spreading.
Thrombosis and haemostasis 1998;79(4):824-31.
1998: Christine Grimaldi; F Chen; C Wu; H J Weiss; Barry S Coller; Deborah L French
Glycoprotein IIb Leu214Pro mutation produces glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa.
Blood 1998;91(5):1562-71.
1998: Barry S Coller
Monitoring platelet GP IIb/IIIa antagonist therapy.
Circulation 1998;97(1):5-9.
1997: Barry S Coller
Monitoring platelet GP IIb/IIIa [corrected] antagonist therapy.
Circulation 1997;96(11):3828-32.
1997: Barry S Coller
Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.
The Journal of clinical investigation 1997;100(11 Suppl):S57-60.
1997: Barry S Coller
GPIIb/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 Fab.
Thrombosis and haemostasis 1997;78(1):730-5.
1997: Fletcher B Taylor; Barry S Coller; Alvin C K Chang; Glenn Peer; R Jordan; W Engellener; Charles T Esmon
7E3 F(ab')2, a monoclonal antibody to the platelet GPIIb/IIIa receptor, protects against microangiopathic hemolytic anemia and microvascular thrombotic renal failure in baboons treated with C4b binding protein and a sublethal infusion of Escherichia coli.
Blood 1997;89(11):4078-84.
1997: Barry S Coller
Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.
The Journal of clinical investigation 1997;99(7):1467-71.
1997: Barry S Coller; D Lang; Lesley E Scudder
Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade.
Circulation 1997;95(4):860-7.
1997: T Ammar; Lesley E Scudder; Barry S Coller
In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonist c7E3 Fab on the activated clotting time.
Circulation 1997;95(3):614-7.
1997: Deborah L French; Barry S Coller
Hematologically important mutations: Glanzmann thrombasthenia.
Blood cells, molecules & diseases 1997;23(1):39-51.
1996: T Ammar; C F Fisher; K Sarier; Barry S Coller
The effects of thrombocytopenia on the activated coagulation time.
Anesthesia and analgesia 1996;83(6):1185-8.
1996: Y Jin; Harry C Dietz; Robert A Montgomery; W R Bell; Iain McIntosh; Barry S Coller; Paul F Bray
Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection.
The Journal of clinical investigation 1996;98(8):1745-54.
1996: Barry S Coller; K M Anderson; H F Weisman
The anti-GPIIb-IIIa agents: fundamental and clinical aspects.
Haemostasis 1996;26 Suppl 4():285-93.
1996: Christine Grimaldi; F Chen; Lesley E Scudder; Barry S Coller; Deborah L French
A Cys374Tyr homozygous mutation of platelet glycoprotein IIIa (beta 3) in a Chinese patient with Glanzmann's thrombasthenia.
Blood 1996;88(5):1666-75.
1996: C L Wagner; Mary Ann Mascelli; D S Neblock; HF Weisman; Barry S Coller; Robert E Jordan
Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets.
Blood 1996;88(3):907-14.
1996: Joan Carles Reverter; Suzette Béguin; H Kessels; R Kumar; Coenraad Hemker; Barry S Coller
Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".
The Journal of clinical investigation 1996;98(3):863-74.
1995: Barry S Coller
Augmentation of thrombolysis with antiplatelet drugs.
Coronary artery disease 1995;6(12):911-4.
1995: Neal S Kleiman; Albert E Raizner; R Jordan; A L Wang; D Norton; K F Mace; A Joshi; Barry S Coller; H F Weisman
Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors.
Journal of the American College of Cardiology 1995;26(7):1665-71.
1995: Barry S Coller
The role of platelets in arterial thrombosis and the rationale for blockade of platelet GPIIb/IIIa receptors as antithrombotic therapy.
European heart journal 1995;16 Suppl L():11-5.
1995: D M Knight; C Wagner; R Jordan; M F McAleer; R DeRita; D N Fass; Barry S Coller; H F Weisman; J Ghrayeb
The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions.
Molecular immunology 1995;32(16):1271-81.
1995: Barry S Coller
Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy.
Circulation 1995;92(9):2373-80.
1995: J J Popma; Barry S Coller; Erik Ohman; J A Bittl; J Weitz; R E Kuntz; M B Leon
Antithrombotic therapy in patients undergoing coronary angioplasty.
Chest 1995;108(4 Suppl):486S-501S.
1995: Barry S Coller; K Anderson; H F Weisman
New antiplatelet agents: platelet GPIIb/IIIa antagonists.
Thrombosis and haemostasis 1995;74(1):302-8.
1995: F Chen; Barry S Coller; D French
[Rapid detection of platelet glycoprotein IIb, IIIA gene variety by single strand conformation polymorphism analysis].
Zhonghua yi xue za zhi 1995;75(6):341-3, 382.
1995: Hava Peretz; Nurit Rosenberg; Saly Usher; E Graff; P J Newman; Barry S Coller; Uri Seligsohn
Glanzmann's thrombasthenia associated with deletion-insertion and alternative splicing in the glycoprotein IIb gene.
Blood 1995;85(2):414-20.
1994: Wadie F Bahou; J L Kutok; A Wong; C L Potter; Barry S Coller
Identification of a novel thrombin receptor sequence required for activation-dependent responses.
Blood 1994;84(12):4195-202.
1994: J L Kutok; Barry S Coller
Partial inhibition of platelet aggregation and fibrinogen binding by a murine monoclonal antibody to GPIIIa: requirement for antibody bivalency.
Thrombosis and haemostasis 1994;72(6):964-72.
1994: Barry S Coller
Current concepts of thrombosis.
The Journal of invasive cardiology 1994;6(8):277-84.
1994: Barry S Coller; U Seligsohn; H Peretz; P J Newman
Glanzmann thrombasthenia: new insights from an historical perspective.
Seminars in hematology 1994;31(4):301-11.
1994: Mortimer Poncz; S Rifat; Barry S Coller; Peter J Newman; Sanford J Shattil; T Parrella; Paolo Fortina; Joel S Bennett
Glanzmann thrombasthenia secondary to a Gly273-->Asp mutation adjacent to the first calcium-binding domain of platelet glycoprotein IIb.
The Journal of clinical investigation 1994;93(1):172-9.
1993: Barry S Coller; J L Kutok; L E Scudder; D K Galanakis; S M West; G S Rudomen; K T Springer
Studies of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogen.
The Journal of clinical investigation 1993;92(6):2796-806.
1993: Barry S Coller; K T Springer; L E Scudder; J L Kutok; M Ceruso; G D Prestwich
Substituting isoserine for serine in the thrombin receptor activation peptide SFLLRN confers resistance to aminopeptidase M-induced cleavage and inactivation.
The Journal of biological chemistry 1993;268(28):20741-3.
1993: K J Norton; Robert M Scarborough; J L Kutok; M A Escobedo; L Nannizzi; Barry S Coller
Immunologic analysis of the cloned platelet thrombin receptor activation mechanism: evidence supporting receptor cleavage, release of the N-terminal peptide, and insertion of the tethered ligand into a protected environment.
Blood 1993;82(7):2125-36.
1993: Wadie F Bahou; Barry S Coller; C L Potter; K J Norton; J L Kutok; Michael S Goligorsky
The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activation.
The Journal of clinical investigation 1993;91(4):1405-13.
1992: Barry S Coller; P Ward; M Ceruso; L E Scudder; K Springer; J Kutok; G D Prestwich
Thrombin receptor activating peptides: importance of the N-terminal serine and its ionization state as judged by pH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase M.
Biochemistry 1992;31(47):11713-20.
1992: Barry S Coller
Economic benefits of biomedical research support.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1992;6(8):2509.
1992: Barry S Coller; K T Springer; J H Beer; N Mohandas; L E Scudder; K J Norton; S M West
Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions.
The Journal of clinical investigation 1992;89(2):546-55.
1992: J H Beer; K T Springer; Barry S Coller
Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor.
Blood 1992;79(1):117-28.
1992: Barry S Coller
Antiplatelet agents in the prevention and therapy of thrombosis.
Annual review of medicine 1992;43():171-80.
1992: L E Scudder; E L Kalomiris; Barry S Coller
Preparation and functional characterization of monoclonal antibodies against glycoprotein Ib.
Methods in enzymology 1992;215():295-311.
1991: Barry S Coller; U Seligsohn; S M West; L E Scudder; K J Norton
Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking.
Blood 1991;78(10):2603-10.
1991: H Peretz; U Seligsohn; E Zwang; Barry S Coller; P J Newman
Detection of the Glanzmann's thrombasthenia mutations in Arab and Iraqi-Jewish patients by polymerase chain reaction and restriction analysis of blood or urine samples.
Thrombosis and haemostasis 1991;66(4):500-4.
1991: Peter J Newman; U Seligsohn; S Lyman; Barry S Coller
The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(8):3160-4.
1991: Barry S Coller; L E Scudder; J Beer; H K Gold; J D Folts; J Cavagnaro; R Jordan; C Wagner; J Iuliucci; D Knight
Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agents.
Annals of the New York Academy of Sciences 1991;614():193-213.
1991: C D Burk; Peter J Newman; S Lyman; J Gill; Barry S Coller; Mortimer Poncz
A deletion in the gene for glycoprotein IIb associated with Glanzmann's thrombasthenia.
The Journal of clinical investigation 1991;87(1):270-6.
1991: Barry S Coller; D A Cheresh; E Asch; U Seligsohn
Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel.
Blood 1991;77(1):75-83.
1990: Herman K Gold; Lawrence W Gimple; T Yasuda; R C Leinbach; W Werner; R Holt; R Jordan; H Berger; Désiré Collen; Barry S Coller
Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.
The Journal of clinical investigation 1990;86(2):651-9.
1990: B M Golub; P A Sibony; Barry S Coller
Protein S deficiency associated with central retinal artery occlusion.
Archives of ophthalmology 1990;108(7):918.
1990: Barry S Coller
Platelets and thrombolytic therapy.
The New England journal of medicine 1990;322(1):33-42.
1989: Barry S Coller; J D Folts; S R Smith; L E Scudder; R Jordan
Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors.
Circulation 1989;80(6):1766-74.
1989: J Beer; Barry S Coller
Evidence that platelet glycoprotein IIIa has a large disulfide-bonded loop that is susceptible to proteolytic cleavage.
The Journal of biological chemistry 1989;264(29):17564-73.
1989: Barry S Coller
The newly dead as research subjects.
Clinical research 1989;37(3):487-94.
1989: Lawrence W Gimple; Herman K Gold; R C Leinbach; Barry S Coller; W Werner; T Yasuda; J A Johns; A A Ziskind; D Finkelstein; Désiré Collen
Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator.
Circulation 1989;80(3):581-8.
1989: U Seligsohn; Barry S Coller; A Zivelin; E F Plow; M H Ginsberg
Immunoblot analysis of platelet glycoprotein IIb in patients with Glanzmann thrombasthenia in Israel.
British journal of haematology 1989;72(3):415-23.
1989: Barry S Coller; J H Beer; L E Scudder; M H Steinberg
Collagen-platelet interactions: evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins.
Blood 1989;74(1):182-92.
1988: Barry S Coller
Thromboembolism and air travel.
Lancet 1988;2(8622):1255.
1988: M E Russell; U Seligsohn; Barry S Coller; M H Ginsberg; P Skoglund; T Quertermous
Structural integrity of the glycoprotein IIb and IIIa genes in Glanzmann thrombasthenia patients from Israel.
Blood 1988;72(5):1833-6.
1988: Barry S Coller; L E Scudder; H J Berger; J D Iuliucci
Inhibition of human platelet function in vivo with a monoclonal antibody. With observations on the newly dead as experimental subjects.
Annals of internal medicine 1988;109(8):635-8.
1988: Simon Karpatkin; E Pearlstein; C Ambrogio; Barry S Coller
Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo.
The Journal of clinical investigation 1988;81(4):1012-9.
1988: Herman K Gold; Barry S Coller; T Yasuda; T Saito; J T Fallon; J Luis Guerrero; R C Leinbach; A A Ziskind; Désiré Collen
Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation.
Circulation 1988;77(3):670-7.
1988: Uri Seligsohn; R S Mibashan; C H Rodeck; K H Nicolaides; D S Millar; Barry S Coller
Prevention program of type I Glanzmann thrombasthenia in Israel: prenatal diagnosis.
Current studies in hematology and blood transfusion 1988;(55):174-9.
1987: M H Steinberg; J G Kelton; Barry S Coller
Plasma glycocalicin. An aid in the classification of thrombocytopenic disorders.
The New England journal of medicine 1987;317(17):1037-42.
1987: Barry S Coller; J Owen; Jolyon Jesty; D Horowitz; M J Reitman; J Spear; T Yeh; P C Comp
Deficiency of plasma protein S, protein C, or antithrombin III and arterial thrombosis.
Arteriosclerosis (Dallas, Tex.) 1987;7(5):456-62.
1987: Barry S Coller; U Seligsohn; P A Little
Type I Glanzmann thrombasthenia patients from the Iraqi-Jewish and Arab populations in Israel can be differentiated by platelet glycoprotein IIIa immunoblot analysis.
Blood 1987;69(6):1696-703.
1987: Barry S Coller
Diagnostic and therapeutic applications of antiplatelet monoclonal antibodies.
Biorheology 1987;24(6):649-58.
1987: Barry S Coller
Blood elements at surfaces: platelets.
Annals of the New York Academy of Sciences 1987;516():362-79.
1986: Barry S Coller; J D Folts; L E Scudder; S R Smith
Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model.
Blood 1986;68(3):783-6.
1986: Barry S Coller
Activation affects access to the platelet receptor for adhesive glycoproteins.
The Journal of cell biology 1986;103(2):451-6.
1986: K S Sakariassen; P F Nievelstein; Barry S Coller; Jan J Sixma
The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium.
British journal of haematology 1986;63(4):681-91.
1986: M H Steinberg; S Saletan; M Funt; D Baker; Barry S Coller
Management of factor XI deficiency in gynecologic and obstetric patients.
Obstetrics and gynecology 1986;68(1):130-3.
1986: M P Gounder; D Baker; S Saletan; A G Monheit; M B Hultin; Barry S Coller
Intravenous gammaglobulin therapy in the management of a patient with idiopathic thrombocytopenic purpura and a warm autoimmune erythrocyte panagglutinin during pregnancy.
Obstetrics and gynecology 1986;67(5):741-6.
1986: Barry S Coller; U Seligsohn; A Zivelin; E Zwang; A Lusky; M Modan
Immunologic and biochemical characterization of homozygous and heterozygous Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations of Israel: comparison of techniques for carrier detection.
British journal of haematology 1986;62(4):723-35.
1986: Barry S Coller; E I Peerschke; U Seligsohn; L E Scudder; A T Nurden; J P Rosa
Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
The Journal of laboratory and clinical medicine 1986;107(4):384-92.
1986: M D Ezekowitz; Barry S Coller; S C Srivastava
Potential application of labeled antibodies for thrombus detection.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1986;13(4):407-11.
1986: H A Coller; Barry S Coller
Poisson statistical analysis of repetitive subcloning by the limiting dilution technique as a way of assessing hybridoma monoclonality.
Methods in enzymology 1986;121():412-7.
1986: A D Michelson; J Loscalzo; B Melnick; Barry S Coller; R I Handin
Partial characterization of a binding site for von Willebrand factor on glycocalicin.
Blood 1986;67(1):19-26.
1985: Uri Seligsohn; R S Mibashan; C H Rodeck; K H Nicolaides; D S Millar; Barry S Coller
Prenatal diagnosis of Glanzmann's thrombasthenia.
Lancet 1985;2(8469-70):1419.
1985: Barry S Coller; L E Scudder
Inhibition of dog platelet function by in vivo infusion of F(ab')2 fragments of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor.
Blood 1985;66(6):1456-9.
1985: E L Kalomiris; Barry S Coller
Thiol-specific probes indicate that the beta-chain of platelet glycoprotein Ib is a transmembrane protein with a reactive endofacial sulfhydryl group.
Biochemistry 1985;24(20):5430-6.
1985: E F Plow; R P McEver; Barry S Coller; V L Woods; G Marguerie; M H Ginsberg
Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated human platelets.
Blood 1985;66(3):724-7.
1985: Barry S Coller
A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.
The Journal of clinical investigation 1985;76(1):101-8.
1985: A Eldor; I Vlodavsky; U Martinowicz; Z Fuks; Barry S Coller
Platelet interaction with subendothelial extracellular matrix: platelet-fibrinogen interactions are essential for platelet aggregation but not for the matrix-induced release reaction.
Blood 1985;65(6):1477-83.
1985: Z H Oster; S C Srivastava; P Som; G E Meinken; L E Scudder; K Yamamoto; H L Atkins; A B Brill; Barry S Coller
Thrombus radioimmunoscintigraphy: an approach using monoclonal antiplatelet antibody.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(10):3465-8.
1985: H R Gralnick; M A Flaum; C M Kessler; H Zimbler; Barry S Coller
IgA inhibitor to factor VIII/von Willebrand factor.
British journal of haematology 1985;59(1):149-58.
1985: H R Grainick; SB Williams; Barry S Coller
Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
The Journal of clinical investigation 1985;75(1):19-25.
1984: H R Gralnick; S B Williams; Barry S Coller
Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin.
Blood 1984;64(4):797-800.
1984: E I Peerschke; Barry S Coller
A murine monoclonal antibody that blocks fibrinogen binding to normal platelets also inhibits fibrinogen interactions with chymotrypsin-treated platelets.
Blood 1984;64(1):59-63.
1984: Barry S Coller
Report of the working party on hybridoma-derived monoclonal antibodies to platelets.
Thrombosis and haemostasis 1984;51(2):169-73.
1984: Barry S Coller
Bizzozero and the discovery of the blood platelet.
Lancet 1984;1(8380):804.
1984: Barry S Coller; E Kalomiris; M Steinberg; L E Scudder
Evidence that glycocalicin circulates in normal plasma.
The Journal of clinical investigation 1984;73(3):794-9.
1983: Barry S Coller; E I Peerschke; L E Scudder; C A Sullivan
A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.
The Journal of clinical investigation 1983;72(1):325-38.
1983: H A Coller; Barry S Coller
Statistical analysis of repetitive subcloning by the limiting dilution technique with a view toward ensuring hybridoma monoclonality.
Hybridoma 1983;2(1):91-6.
1983: Barry S Coller; E I Peerschke; L E Scudder; C A Sullivan
Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor.
Blood 1983;61(1):99-110.
1983: Barry S Coller
Biochemical and electrostatic considerations in primary platelet aggregation.
Annals of the New York Academy of Sciences 1983;416():693-708.
1982: R A Lipton; J Ayromlooi; Barry S Coller
Severe von Willebrand's disease during labor and delivery.
JAMA : the journal of the American Medical Association 1982;248(11):1355-7.
1982: Barry S Coller
Effects of tertiary amine local anesthetics on von Willebrand factor-dependent platelet function: alteration of membrane reactivity and degradation of GPIb by a calcium-dependent protease(s).
Blood 1982;60(3):731-43.
1981: Barry S Coller; M B Hultin; L W Hoyer; F Miller; J V Dobbs; M H Dosik; E R Berger
Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosis.
Blood 1981;58(3):619-24.
1981: Barry S Coller; M H Zarrabi
Platelet membrane studies in the May-Hegglin anomaly.
Blood 1981;58(2):279-84.
1981: Barry S Coller
Inhibition of von Willebrand factor-dependent platelet function by increased platelet cyclic AMP and its prevention by cytoskeleton-disrupting agents.
Blood 1981;57(5):846-55.
1980: Barry S Coller
Effects of alpha 1-acid glycoprotein on ristocetin, thrombin and Polybrene induced platelet aggregation.
Thrombosis research 1980;18(3-4):579-84.
1980: Barry S Coller
Polybrene-induced platelet agglutination and reduction in electrophoretic mobility: enhancement by von Willebrand factor and inhibition by vancomycin.
Blood 1980;55(2):276-81.
1980: Barry S Coller
Interaction of normal, thrombasthenic, and Bernard-Soulier platelets with immobilized fibrinogen: defective platelet-fibrinogen interaction in thrombasthenia.
Blood 1980;55(2):169-78.
1979: Barry S Coller
Asialofibrinogen supports platelet aggregation and adhesion to glass.
Blood 1979;53(2):325-32.
1979: R P Warrell; M B Hultin; Barry S Coller
Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure.
The American journal of medicine 1979;66(2):226-8.
1979: Barry S Coller; D N Fass
Electrophoretic mobility of platelets from normal and bleeder swine.
Thrombosis research 1979;15(1-2):281-5.
1979: H R Gralnick; Barry S Coller; J C Fratantoni; J Martinez
Fibrinogen bethesda III: a hypodysfibrinogenemia.
Blood 1979;53(1):28-46.
1978: Barry S Coller
The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility.
The Journal of clinical investigation 1978;61(5):1168-75.
1978: Barry S Coller; Robert N Frank; R C Milton; H R Gralnick
Plasma cofactors of platelet function: correlation with diabetic retinopathy and hemoglobins Ala-c.
Annals of internal medicine 1978;88(3):311-6.
1977: Barry S Coller; H R Gralnick
Studies on the mechanism of ristocetin-induced platelet agglutination. Effects of structural modification of ristocetin and vancomycin.
The Journal of clinical investigation 1977;60(2):302-12.
1977: H R Gralnick; Y Sultan; Barry S Coller
Von Willebrand's disease: combined qualitative and quantitative abnormalities.
The New England journal of medicine 1977;296(18):1024-30.
1977: Barry S Coller; B A Chabner; H R Gralnick
Frequencies and patterns of bone marrow involvement in non-Hodgkin lymphomas: observations on the value of bilateral biopsies.
American journal of hematology 1977;3():105-19.
1976: Barry S Coller; B R Franza; H R Gralnick
The pH dependence of quantitative ristocetin-induced platelet aggregation: theoretical and practical implications-a new device for maintenance of platelet-rich plasma pH.
Blood 1976;47(5):841-54.
1976: H R Gralnick; Barry S Coller
Molecular defects in haemophilia A and von Willebrand's disease.
Lancet 1976;1(7964):837-8.
1976: H R Gralnick; Barry S Coller; Y Sultan
Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants.
Science (New York, N.Y.) 1976;192(4234):56-9.
1976: Barry S Coller; H R Gralnick
The effect of stir bar size and shape on quantitative platelet aggregation.
Thrombosis research 1976;8(2):121-9.
1975: Barry S Coller; H R Gralnick
Proceedings: Variations in quantitative ristocetin platelet aggregation (RPA) with time after platelet rich plasma (PRP) preparation: association with alteration in pH.
Thrombosis et diathesis haemorrhagica 1975;34(2):581-2.
1975: H R Gralnick; Barry S Coller; Y Sultan
Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
The Journal of clinical investigation 1975;56(4):814-27.
1975: Barry S Coller; W B Lundberg; H R Gralnick
Effects of vancomycin on platelets, plasma proteins and hepatitis B surface antigen.
Thrombosis et diathesis haemorrhagica 1975;34(1):83-93.
1975: H R Gralnick; Barry S Coller
Studies of the human factor VIII/von Willebrand's factor protein. II. Identification and characterization of the von Willebrand protein.
Blood 1975;46(3):417-30.
1975: Barry S Coller; R J Hirschman; H R Gralnick
Studies on the Factor VIII/von Willebrand factor antigen on human platelets.
Thrombosis research 1975;6(6):469-80.
1975: I M Goldstein; Barry S Coller
Aplastic anemia in pregnancy: recovery after normal spontaneous delivery.
Annals of internal medicine 1975;82(4):537-9.
1975: H R Gralnick; Barry S Coller; S L Marchesi
Studies of the human factor VIII/von Willebrand's factor protein I. Comparison of the protein found in normal, von Willebrand's disease and hemophilia A.
Thrombosis research 1975;6(2):93-108.
1975: H R Gralnick; S L Marchesi; Barry S Coller
Theoretical approach to molecular biology of factor VIII: heterogeneity of the molecule.
Annals of the New York Academy of Sciences 1975;240():378-88.
1974: Barry S Coller; W B Lundberg; L Albright; A K Ommaya; H R Gralnick
Letter: Positive antiglobulin test after BCG immunotherapy.
The New England journal of medicine 1974;291(9):474.
1973: H R Gralnick; Barry S Coller; S L Marchesi
Immunological studies of factor VIII in haemophilia and von Willebrand's disease.
Nature: New biology 1973;244(139):281-2.
1973: R J Hirschman; R A Yankee; Barry S Coller; H R Gralnick
Sensitive methods for the detection and characterization of platelet isoantibodies.
Thrombosis et diathesis haemorrhagica 1973;29(2):408-15.
1972: M B Zucker; P L Rifkin; N M Friedberg; Barry S Coller
Mechanisms of platelet function as revealed by the retention of platelets in glass bead columns.
Annals of the New York Academy of Sciences 1972;201():138-44.
1971: Barry S Coller; M B Zucker
Reversible decrease in platelet retention by glass bead columns (adhesiveness) induced by disturbing the blood.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1971;136(3):769-71.